PTC Therapeutics PTCT
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts12
Average target$100.00+77.2% vs. price
- Buy 83%
- Hold 17%
Low $62.00Now $56.42Avg $100.00High $137.00
Recent rating changes
The last 20 actions on file set price targets from $62.00 to $137.00, averaging $98.24.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | J.P. Morgan | BUY | $92.00 |
| 2 Nov 2026 | Citi | BUY | $109.00 |
| 2 Nov 2026 | Barclays | BUY | $122.00 |
| 2 Nov 2026 | J.P. Morgan | BUY | $92.00 |
| 30 Oct 2026 | TD Cowen | BUY | $95.00 |
| 30 Oct 2026 | Wells Fargo | BUY | $112.00 |
| 30 Oct 2026 | UBS | BUY | $90.00 |
| 30 Oct 2026 | BofA Securities | BUY | – |
| 29 Oct 2026 | Cantor Fitzgerald | BUY | $137.00 |
| 29 Oct 2026 | RBC Capital | HOLD | $77.00 |
| 27 Oct 2026 | RBC Capital | HOLD | $75.00 |
| 20 Oct 2026 | Raymond James | BUY | $106.00 |
| 19 Oct 2026 | Wells Fargo | BUY | $109.00 |
| 16 Oct 2026 | UBS | BUY | $90.00 |
| 16 Oct 2026 | Truist Financial | HOLD | $62.00 |
| 15 Oct 2026 | UBS | BUY | $90.00 |
| 14 Oct 2026 | UBS | BUY | $90.00 |
| 14 Oct 2026 | J.P. Morgan | BUY | – |
| 9 Oct 2026 | BofA Securities | BUY | – |
| 7 Oct 2026 | Barclays | BUY | $122.00 |
No comments yet — be the first to weigh in on PTCT.
Sign in to join the discussion.